A Pragmatic Approach to Manage Long-Term Adverse Effects in CML Treatment Abstract Introduction and Objectives: Chronic Myeloid Leukemia (CML) is a hematologic malignancy effectively managed with tyrosine kinase inhibitors (TKIs). Despite their success in prolonging survival, TKIs are associated with long-term adverse effects that can significantly impact patient quality of life and treatment adherence. This